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ABSTRACT  25 
 26 
Purpose: To determine whether melanopsin expressing intrinsically photosensitive Retinal 27 
Ganglion Cell (ipRGC) inputs to the pupil light reflex (PLR) are affected in early age-related 28 
macular degeneration (AMD).  29 
Methods: The PLR was measured in 40 participants (20 early AMD and 20 age-matched 30 
controls) using a custom-built Maxwellian-view pupillometer. Sinusoidal stimuli (0.5 Hz, 31 
11.9 s duration, 35.6° diameter) were presented to the study eye and the consensual pupil 32 
response was measured for stimuli with high melanopsin excitation (464nm; blue) and with 33 
low melanopsin excitation (638 nm; red) that biased activation to the outer retina. Two 34 
melanopsin PLR metrics were quantified: the Phase Amplitude Percentage (PAP) during the 35 
sinusoidal stimulus presentation and the Post-Illumination Pupil Response (PIPR). The PLR 36 
during stimulus presentation was analyzed using latency to constriction, transient pupil 37 
response and maximum pupil constriction metrics. Diagnostic accuracy was evaluated using 38 
receiver operating characteristic (ROC) curves. 39 
Results: The blue PIPR was significantly less sustained in the early AMD group (p<0.001). 40 
The red PIPR was not significantly different between groups (p>0.05). The PAP and blue 41 
stimulus constriction amplitude were significantly lower in the early AMD group (p < 0.05). 42 
There was no significant difference between groups in the latency or transient amplitude for 43 
both stimuli (p>0.05). ROC analysis showed excellent diagnostic accuracy for the blue PIPR 44 
metrics (AUC>0.9).   45 
Conclusions: This is the initial report that the melanopsin controlled PIPR is dysfunctional in 46 
early AMD. The non-invasive, objective measurement of the ipRGC controlled PIPR has 47 
excellent diagnostic accuracy for early AMD. 48 
 49 
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  55 
INTRODUCTION  56 
 57 
Melanopsin-expressing intrinsically photosensitive Retinal Ganglion Cells (ipRGCs) form the 58 
recently identified third photoreceptor class in the eye and have important non-image forming 59 
functions including mediation of the pupillary response1, 2 and photoentrainment of circadian 60 
rhythm.3-6 Their cell bodies are primarily located in the ganglion cell layer, with a small 61 
number displaced to the inner nuclear layer.7 While ipRGC physiology and function has been 62 
studied in both nocturnal rodents5, 8 and primates,9, 10 research is increasingly focusing on 63 
their roles in diurnal humans and in particular in diseased eyes, with preliminary reports for 64 
potential ipRGC dysfunction in age-related macular degeneration (AMD).11 65 
Psychophysical and electrophysiological studies are well established for measuring functional 66 
deficits of rods and cones in different stages of AMD12-19 however, the effect of AMD on 67 
ipRGC function is unknown. The Pupil Light Reflex (PLR) provides a rapid, objective, non-68 
invasive measure of both inner (ipRGC) and outer (rod and cone) retinal function.6, 11, 20-25 69 
Following onset of an incremental light pulse, the initial PLR is mediated by the outer retina20, 70 
26 with increasing melanopsin input with longer stimulus durations,20 while ipRGCs control 71 
the Post-Illumination Pupil Response (PIPR), the sustained pupil constriction after light 72 
offset.2, 11, 25 Recently it was demonstrated that for sinusoidal lights with high melanopsin 73 
excitation, the peak-to-trough amplitude of the phasic PLR during flicker stimulation was 74 
suppressed compared to lights with low melanopsin excitation.11, 27 This suppression is 75 
analysed using a Phase Amplitude Percentage (PAP) metric to provide a direct marker of 76 
melanopsin inputs to the pupil during light stimulation.11 77 
IpRGC function has been measured using the PIPR in diabetic patients without diabetic 78 
retinopathy,28 glaucoma,29-31 retinitis pigmentosa,6, 32, 33 Leber’s hereditary optic neuropathy34 79 
and retinal dystrophy.35 In AMD, the PLR has been used as a measure of outer retinal 80 
function11, 36-41 and demonstrates a longer latency to constriction and reduction in maximum 81 
pupil constriction amplitude. However, these studies were not designed to measure ipRGC 82 
function in AMD. Pathological changes in AMD first occur in the paracentral retina42 where 83 
ipRGCs have their highest density,9, 10 which may make ipRGCs susceptible during early 84 
disease. In advanced stages of the disease, there is ~50% loss of inner retinal ganglion cells.43 85 
Although ipRGCs are robust in early stages of diseases affecting the optic nerve,44 it is still 86 
not known how ipRGCs are affected in patients with early AMD, with our group showing the 87 
first evidence of ipRGC alteration.11 The primary purpose of this study is to measure the 88 
effect of early AMD on inner retinal contributions to the PLR using the PIPR metric and to 89 
use a novel sinusoidal stimulus paradigm that reflects inner retina (ipRGCs) and outer retina 90 
(rods and cones) interactions in the phasic pupil response.11  91 
 92 
METHODS 93 
 94 
Participants 95 
Forty participants (20 female, 20 male) were recruited from the Queensland University of 96 
Technology (QUT) eye clinic. Twenty participants (10F and 10M; age 69.3 ± 5.5 years) were 97 
healthy controls and 20 were participants with early AMD (10F and 10M; age 72.9 ± 6.3 98 
years) who had either AREDS grade 2 or grade 3 AMD (Table 1) based on the results of two 99 
independent gradings of the fundus photographs.45 Where early AMD was present in both 100 
eyes, the patients preferred eye was measured. Where participants had grade 1 in one eye, the 101 
eye with early AMD was chosen as the study eye. Participants with Grade 4 (advanced) in 102 
either eye were excluded. All participants underwent an ophthalmic examination, which 103 
included visual acuity (Bailey Lovie), ophthalmoscopy, colour vision (Lanthony D-15 104 
desaturated), tonometry (iCare TA01, Finland), optical coherence topography (OCT, Cirrus 105 
HD-OCT; Carl Zeiss Meditec, USA) and colour fundus photography (CR-1, Canon, 106 
Australia). The control group had normal vision (6/6 or better), crystalline lens opacities ≤ 107 
Grade 2,46 no ocular disease and were in good general health. The early AMD group had a 108 
best corrected visual acuity ≥ 6/9 in the study eye, crystalline lens opacities ≤  Grade 246 and 109 
no history of ocular or systemic disease other than AMD. No participant had taken any 110 
medication that could affect the pupil response. Written informed consent was obtained from 111 
all participants and the study was conducted in accordance with the requirements of the 112 
Queensland University of Technology Human Research Ethics Committee and the tenets of 113 
the Declaration of Helsinki. 114 
 115 
Table 1: Grading of each eye for all AMD patients according to AREDS grading scale with the 116 
study eye in bold. 117 
 Grade   Grade 
Px No. RE LE  Px No. RE LE 
1 2b 2b  11 3a 3c 
2 3d 2a  12 3a 3a 
3 2c 2b  13 3c 3c 
4 2b 2b  14 2a 2b 
5 1 2c  15 2b 2b 
6 3d 2b  16 2c 1 
7 2b 2b  17 2a 3 
8 2b 2b  18 3c 3c 
9 2b 2b  19 3a 3d 
10 3a 3c  20 3c 3c 
 118 
 119 
Pupillometer 120 
Sinusoidal stimuli (0.5 Hz, 11.9 s duration) were presented using a custom built, extended 121 
Maxwellian view pupillometer11, 23 comprising narrowband LED light sources (638 nm and 122 
464 nm) imaged in the pupil plane via two Fresnel lenses (100 mm diameter, 127 mm and 70 123 
mm focal lengths; Edmund Optics, Singapore) and a 5˚ light shaping diffuser (Physical Optics 124 
Corp., California, USA) to provide a 35.6˚ diameter light stimulus (retinal image diameter: 125 
15.4 mm).25 The consensual pupil light reflex was recorded under infrared LED illumination 126 
(λmax = 851 nm) using a Pixelink camera (IEEE-1394, PL-B741 Fire Wire; 640 x 480 pixels; 127 
60 frames/s) through a telecentric lens (Computar 2/3ʺ 55 mm and 2 x extender C-Mount).25 128 
Customized Matlab software (version 7.12.0, Mathworks, Massachusetts, USA) controlled 129 
stimulus presentation and timing. Blink artefacts were identified and extracted during 130 
software analysis of pupil recordings by a customized algorithm using linear interpolation.25 131 
The spectral outputs of the LED stimuli were measured with a Spectroradiometer (StellarNet, 132 
Florida, USA) and irradiance was calibrated with an ILT1700 Research Radiometer 133 
(International Light Technologies, Massachusetts, USA).  134 
 135 
Procedure 136 
After an initial ophthalmic assessment, Tropicamide 1% (Minims, Chauvin Pharmaceuticals 137 
Ltd., England) was instilled in the study eye and a 15 minute dark adaptation period 138 
commenced in a darkened (< 1 lux) laboratory prior to pupil recordings. The participant was 139 
then aligned in the pupillometer in Maxwellian view with the head held steady by temple bars 140 
and a head brace. The participant was instructed to look straight ahead in the dark as if 141 
fixating a distant object and fixation was monitored with the IR camera. The consensual pupil 142 
reflex was measured in response to short wavelength light (464nm) with high melanopsin 143 
excitation2, 3, 21, 22 and to long wavelength light (638 nm) that biased activation to the outer 144 
retina21 and provided a control. The corneal irradiance of the long and short wavelength 145 
stimuli was 15.1 log quanta.cm-2.s-1. This provided a retinal irradiance of 14.5 log quanta.cm-146 
2.s-1 for short wavelength and 14.9 log quanta.cm-2.s-1 for long wavelength light.47 A single 147 
pupil recording comprised a 10 s pre-stimulus period, presentation of an 11.9 s sinusoidal 148 
stimulus and a 40 s post-illumination period. Two repeats for each stimulus (464 nm and 638 149 
nm) were recorded with a five minute dark adaptation period between trials.27 The short and 150 
long wavelength stimuli were alternated in all sessions with the long wavelength light always 151 
presented first to control for the effect of melanopsin bistability.48 All measurements were 152 
completed during a similar time of day to control for the effect of circadian variation on the 153 
PIPR.49  154 
 155 
Analysis 156 
Figure 1 shows the average pupil light reflex of 20 control participants with no retinal 157 
abnormalities in response to an 11.9 s, 0.5 Hz sinewave stimulus of long (638 nm; red) or 158 
short (464 nm; blue) wavelength light. The PLR was described with linear and exponential 159 
models11, 49 and analyzed according to protocols defined by Adhikari, Zele and Feigl.25 To 160 
control for individual differences in resting pupil diameter, all data are reported as a 161 
percentage of the resting baseline pupil diameter (average pupil diameter during 10 s pre-162 
stimulus period). The PLR during stimulus presentation was quantified using the transient 163 
pupil response (maximum constriction at 500 ms after stimulus onset), latency to constriction 164 
(time taken to constrict 1% of baseline pupil diameter) and constriction amplitude (minimum 165 
pupil diameter during presentation of light stimulus); a smaller percentage value indicates 166 
larger constriction amplitude (Figure 1). The PIPR was quantified at 6 s (sustained pupil 167 
constriction at six seconds after light stimulus offset) and plateau (derived from the 168 
exponential model fit to the PIPR). The Phase Amplitude Percentage (PAP)11 was calculated 169 
as the percentage difference in peak-to-trough amplitude between the phasic pupil response 170 
during light stimulation to the long and short wavelength sinewave stimuli.  171 
Statistical analyses were performed using commercially available statistical software (IBM 172 
SPSS, version 21; IBM Corporation, Armonk, NY, USA). Parametric tests were applied to all 173 
data that passed the Kolmogorov-Smirnov test of normality. Each metric was evaluated by 174 
comparing red and blue stimulus responses within and between groups using repeated 175 
measures ANOVA and appropriate post-hoc analysis was performed when significant effects 176 
occurred. The latency to constriction was not normally distributed and an independent 177 
samples Mann-Whitney U test was used to compare between groups. The PAP was evaluated 178 
using independent samples t-test. A p-value of < 0.05 was considered statistically significant. 179 
The diagnostic accuracy of the PIPR metrics in determining early AMD was evaluated using 180 
receiver operator characteristic (ROC) analysis by quantifying the difference between the 181 
AMD patients and control participants.  182 
 183 
RESULTS 184 
 185 
Figure 2 shows the mean PLR and 95% confidence limits in response to long and short 186 
wavelength stimuli for the early AMD group compared to the healthy controls. Table 2 gives 187 
the PLR metrics for the early AMD group and control group. The AMD patients with AREDS 188 
grade 2 and grade 3 were not significantly different on any PLR metric and therefore the 189 
AMD data were pooled for comparison with the control group. The PLR to the blue stimulus 190 
was significantly different between groups for the 6 s PIPR (F 1, 39 = 64.56, p < 0.0001; Figure 191 
3A), plateau PIPR (F 1, 39 = 33.78, p < 0.0001; Figure 3B) and maximum constriction (F 1, 39 = 192 
8.69, p = 0.005; Figure 4C) where the amplitude was significantly less for the early AMD 193 
group compared to the control group. There was no significant difference between groups in 194 
the transient pupil response (F 1, 39 = 0.89, p = 0.351; Figure 4A) or latency to constriction (p 195 
= 0.947; Figure 4B) for the blue stimulus. The PLR to the red stimulus was not significantly 196 
different between groups for any metric (p > 0.05). There was a significant difference (p < 197 
0.05) between the red and blue stimulus response for all metrics except for latency to 198 
constriction (p > 0.05). Analysis of the PAP (Figure 4D) showed a significantly lower average 199 
percentage in the early AMD group (29.5 ± 9.4 %) compared to the control group (38.4 ± 200 
11.5 %; t (38) = 2.375, p = 0.023). The slope of the linear regression of the 6 s PIPR 201 
amplitude as a function of age was not significantly different from zero indicating that there 202 
was no effect of age on the PIPR (R2 = 0.113, F1,19 = 2.291, p = 0.147). There was no 203 
significant relationship between visual acuity and the PIPR metrics. The ROC analysis 204 
showed that the blue stimulus had a larger AUC for both the 6 s PIPR (AUC = 0.963, p < 205 
0.001) and plateau PIPR metric (AUC = 0.928, p <0.001) compared to the red control 206 
stimulus (6 s: AUC = 0.660, p = 0.083; plateau: AUC = 0.401, p = 0.298) (Figure 5). 207 
 208 
 209 
Table 2: Pupil light reflex (PLR) metrics (μ ± σ) in healthy controls and patients with early age-210 
related macular degeneration  211 
 212 
DISCUSSION 213 
 214 
This is the initial demonstration of a significantly reduced post-illumination pupil response in 215 
persons with early age related macular degeneration. These findings indicate that intrinsic 216 
ipRGC inputs to the pupil control pathway are altered in early AMD and the pupillometric 217 
measurement of the PIPR has excellent (AUC > 0.90) diagnostic accuracy for early AMD. By 218 
comparison, pupil parameters reflecting outer retinal contributions to the PLR (transient and 219 
latency)10, 11, 26 were not significantly affected. However, the large stimuli used in this study 220 
were selected to optimize ipRGC activation11 and would therefore be less sensitive to the 221 
presence of small, localized outer retinal deficits as can occur due to drusen.50, 51 222 
The exact pathomechanisms in AMD are unclear, with known loss of conventional retinal 223 
ganglion cells (RGC) in advanced stages of AMD;43 previous histological studies did not 224 
study ipRGCs as they have been only recently discovered.7 The relative numbers of different 225 
subtypes of ipRGCs may vary between species. There are at least five ipRGC subtypes (M1 to 226 
M5) that have been identified in transgenic mouse models based on their dendritic 227 
stratification that varies across the outer and inner laminae of the inner plexiform layer (IPL).9 228 
IpRGC dendrites express melanopsin and have comparable photon capture to the soma 52 229 
 Blue stimulus  Red stimulus 
 AMD Control AMD Control 
Latency to constriction (ms) 209.6 ± 88.4 211.4 ± 89.1 219.4 ± 83.1 217.5 ± 87.7 
Transient pupil response (%) 20.7 ± 8.4 23.4 ± 9.4 18.4 ± 7.3 20.7 ± 7.3 
Maximum constriction (%) 42.9 ± 5.3 * 38.7 ± 3.3 47.8 ± 5.1 45.1 ± 3.9 
6 s PIPR (%) 80.1 ± 6.4 * 63.0 ± 7.3 90.0 ± 4.2 87.5 ± 4.1 
Plateau PIPR (%) 92.0 ± 4.6 * 75.6 ± 11.7 96.5 ± 4.9 96.9 ± 3.3 
* p < 0.05    
while also receiving synapses from bipolar and amacrine cells for signaling between outer and 230 
inner retina.9, 53, 54 There is evidence of at least three ipRGC subtypes in primates10, 55 but it is 231 
unknown how these different subtypes are affected by retinal and optic nerve disease. In 232 
rodent studies of retinal disease, Royal College of Surgeons (RCS) dystrophic rats and P23H 233 
transgenic rats were used to investigate melanopsin cell function in retinitis pigmentosa 234 
(RP).35, 56 One study showed that some ipRGCs were lost with disease progression while a 235 
significant number of ipRGCs survived into advanced stages of degeneration in the far 236 
peripheral retina.35 A second study showed progressive loss in density, cell integrity and 237 
dendritic arborisation of ipRGCs in advanced stages of RP 56 consistent with initial findings 238 
of ipRGC dysfunction in advanced AMD.11 A number of rodent57-59 and human60-62 studies 239 
show that ipRGCs are more resistant compared to conventional retinal ganglion cells in optic 240 
nerve disease and a recent study in a rat model showed that density and dendritic arborization 241 
does not change with age.63 An example of this resistance to damage is shown in a study in 242 
patients with glaucoma that demonstrated the PIPR in patients with early glaucoma was 243 
similar to controls,29 but lower in patients with advanced glaucoma.29, 30 In patients with 244 
Leber’s hereditary optic neuropathy (LHON), the sustained pupil response to blue light in the 245 
affected eye was similar to that in the healthy eye, suggesting a resistance to the intracellular 246 
metabolic disorder affecting the optic nerve caused by a genetic defect.34, 64 This is confirmed 247 
in a histological study of LHON that showed relative sparing of ipRGCs compared to other 248 
retinal ganglion cells.60 Whilst remaining robust to early changes in diseases affecting the 249 
optic nerve or peripheral retina,44 we hypothesize that ipRGCs may be more vulnerable in 250 
diseases affecting the central retina such as AMD.42 No histological study has investigated 251 
ipRGC distribution and potential loss in AMD and our research findings suggest that due to 252 
their restricted number and paracentral location,10 ipRGC damage may become manifest early 253 
in the condition.  254 
Previous studies of the pupil light reflex in AMD focused on the latency to pupil constriction, 255 
transient pupil response and maximum pupil constriction which is largely controlled by the 256 
outer retina,36-40 however these studies included patients with advanced exudative AMD and 257 
the deficit is expected to be larger in later disease stages. Using multifocal pupillography, 258 
Sabeti et al65 found reduced pupil responses in patients with early AMD, however their pupil 259 
paradigm is not designed to measure ipRGC function. While outer retinal deficits may have 260 
been manifest in the patients with early AMD, our testing conditions were primarily aimed 261 
towards optimum ipRGC isolation. Smaller stimuli 66 with retinal irradiance below 262 
melanopsin threshold6, 22, 39, 67 can be useful to also detect deficits in rod and cone function.  263 
A number of metrics have been used to define ipRGC response, namely redilation velocity,29, 264 
49 6 s PIPR,21 plateau PIPR2, 6 and area under curve (AUC).24 In this study, we used the 6 s 265 
and plateau PIPR metrics to measure ipRGC controlled PIPR following a recent study by 266 
Adhikari et al25 who demonstrated that these metrics show the lowest coefficient of variation 267 
for inter and intra-individual measurements. The newly defined PAP metric11 that uses the 268 
phasic response during light stimulation may be also beneficial in measuring inner and outer 269 
retinal interactions. It is thought that the peak-to-trough amplitude for the short wavelength 270 
stimulus is lower than that of the long wavelength stimulus due to the contribution of ipRGCs 271 
to maintain pupil constriction when stimuli have high melanopsin excitation;11, 26, 20 we 272 
hypothesise that if there is ipRGC loss or dysfunction in retinal disease, the capacity of 273 
ipRGCs to maintain pupil constriction during light stimulation will be reduced and result in a 274 
larger outer retinal phasic pupil response such that the phasic pupil response to the stimuli 275 
with high and low melanopsin excitation (e.g. blue and red lights) become more similar (i.e. a 276 
lower PAP). Hence, the lower PAP result in the early AMD group compared to the healthy 277 
controls may indicate the onset of altered inner and outer retinal interactions. It is known for 278 
psychophysical studies that rod-cone interactions measured under mesopic light levels may be 279 
an early marker of dysfunction in people with high risk genotype for AMD.68 The differences 280 
in PIPR shown in this study are unlikely to be due to lens attenuation as participants were 281 
age-matched and those with lens grading above grade 2 were excluded, providing a true 282 
reflection of differences in inner retinal melanopsin function.  283 
In conclusion, this is the initial demonstration of an alteration of ipRGC function as measured 284 
via the PIPR in early AMD. IpRGCs may be more vulnerable to disease affecting the central 285 
retina as opposed to those affecting the peripheral retina or optic nerve. Given that the PIPR is 286 
affected in early AMD and in glaucoma11, 29 but not in for example Leber’s hereditary optic 287 
neuropathy,34 these differences in the ipRGCs mediated pupil responses may help to provide 288 
further insight into the disease pathomechanisms. The PAP findings may be a result of altered 289 
signaling between inner and outer retina.11 Histological studies are required for better 290 
understanding of pathophysiological processes involving ipRGCs in AMD. This study 291 
demonstrates that pupillometry provides a rapid, non-invasive means of measuring the pupil 292 
response to quantify ipRGC function in early stages of AMD. The pupillometry paradigms 293 
introduced here have excellent diagnostic accuracy and may also be useful in monitoring 294 
disease progression.11 295 
 296 
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484 
FIGURE LEGENDS 485 
 486 
Figure 1: Graphic representation of the pupil light reflex (PLR) to long and short 487 
wavelength stimuli in healthy controls. The average pupil light reflex of 20 control 488 
participants with no retinal abnormalities to an 11.9 second, 0.5 Hz sinewave stimulus of long 489 
(638 nm; red) or short (464 nm; blue) wavelength light. Data are presented as a percentage of 490 
the baseline pupil diameter (horizontal dashed line). The 6 s PIPR (vertical dashed line) 491 
measures the pupil diameter six seconds after light offset while the plateau PIPR (horizontal 492 
dotted line) shows the plateau of the exponential fit to the post-stimulus pupil diameter. The 493 
PAP is determined by the average peak to trough amplitude of the red and blue sinewave 494 
pupil response during stimulus presentation. 495 
 496 
Figure 2: Average pupil light reflex (PLR) to long and short wavelength stimuli in early 497 
AMD patients compared to healthy controls. The average pupil light reflex to long (panel 498 
A; red) and short (panel B; blue) wavelength light of early AMD patients compared to healthy 499 
controls. Panel A shows the upper and lower 95% confidence limits for the healthy controls 500 
(shaded) and the mean response for the early AMD group (solid line). Panel B shows the 501 
confidence limits (shaded) and mean response (solid line) for both control and early AMD 502 
groups. The sustained response to blue light, measured at 6 s post-stimulus (vertical line), is 503 
significantly reduced in the early AMD group.  504 
 505 
Figure 3: Post-illumination pupil response to red and blue stimuli in control and early 506 
AMD patients. The post-illumination pupil response to long wavelength (red) and short 507 
wavelength (blue) stimuli measured at 6 s after stimulus offset (panel A) and at the plateau of 508 
the exponential fit to the pupil diameter (panel B). The amplitude is expressed as a percentage 509 
of the average pre-stimulus pupil diameter (baseline). The pupil response was compared 510 
between the control group (unfilled) and early AMD group (pattern filled). There was a 511 
significant difference in pupil response to the blue stimulus between groups for both 6 s and 512 
plateau PIPR metrics with no difference between groups for the red stimulus.  513 
 514 
Figure 4: Average pupil light reflex metrics to red and blue stimuli for the control group 515 
and early AMD group. Each panel compares the PLR during presentation of red or blue 516 
stimuli for the control (unfilled) and early AMD (patterned fill) groups. The transient 517 
response (panel A) and maximum pupil constriction (panel C) are expressed as a percentage 518 
of the baseline pupil diameter while latency to constriction (panel B) is given in milliseconds 519 
(ms). The phase amplitude percentage (PAP) (panel D) is expressed as the percentage 520 
difference in peak-to-trough amplitude between the phasic response to long and short 521 
wavelength sinewave stimuli. Both maximum constriction to the blue stimulus and PAP are 522 
significantly reduced in the AMD group compared to the control group. There is no 523 
significant difference in transient response or latency to constriction between groups for red 524 
and blue stimuli. 525 
 526 
Figure 5: Receiver Operating Characteristic (ROC) curves for blue and red stimulus 527 
conditions for the 6s and plateau PIPR metrics. The sensitivity (true positive rate) is 528 
plotted as a function of specificity (false positive rate) for 6 s (panel A) and plateau (panel B) 529 
PIPR measurements. The blue stimulus (blue line) shows a significantly higher sensitivity and 530 
specificity with a larger AUC compared to the red stimulus (red line) for both metrics.  531 
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